PersADE: a database of personalized adverse drug events and their underlying molecular mechanisms
Open Access
- 11 November 2025
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D1556-D1568
Abstract
As a major burden on global healthcare systems, adverse drug events (ADEs) result in significant morbidity, mortality, and healthcare resource consumption. With the rapid advances in precision medicine, personalized ADEs and their molecular mechanisms are important components of drug repurposing and drug safety improvement. Thus, extensive studies have been conducted to collect valuable information on personalized ADEs, but no database has yet been available to provide such data. In this work, PersADE, a database aiming to provide personalized drug adverse events and their molecular mechanisms, was constructed. It integrated 4 061 772 personalized drug-ADE associations, 31 756 protein-ADE associations, and 108 677 drug-protein interactions, with a particular emphasis on off-target effects. The uniqueness of these data lies in (a) providing demographic characteristics, disease context and drug administration parameters associated with ADEs, enabling stratification of drug-ADE associations; (b) systematically integrating interactions among drugs, human proteins and ADEs, describing the mechanistic insights. Given the growing global focus on precision medicine, PersADE is highly anticipated to significantly impact studies on personalized ADEs and mechanistic explorations by providing researchers and clinicians with evidence-based tools. It is now freely accessible at: https://idrblab.org/PersADEKeywords
Funding Information
- Natural Science Foundations of Zhejiang (RG25H300001)
- National Natural Science Foundation of P.R. China (82373790)
- National Natural Science Foundation of P.R. China (22220102001)
- National Natural Science Foundation of P.R. China (82503970)
- National Natural Science Foundation of P.R. China (82504672)
- National Key R&D Program of P.R. China (2024YFA1307503)
- Information Technology Center and State Key Lab of CAD&CG of Zhejiang University
This publication has 62 references indexed in Scilit:
- Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural NetworkAdvanced Science, 2024
- An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized MedicineClinical Pharmacology & Therapeutics, 2021
- Intravenous Methylprednisolone Versus Oral Prednisolone for West Syndrome: A Randomized Open-Label TrialIndian Journal of Pediatrics, 2021
- US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014JAMA, 2016
- Safety and Tolerability of Empagliflozin in Patients with Type 2 DiabetesClinical Therapeutics, 2016
- Long-term Use of Aspirin and Age-Related Macular DegenerationJAMA, 2012
- The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonistsEuropean Journal of Medicinal Chemistry, 2012
- Active Cascade Screening in Primary Inherited Arrhythmia SyndromesJACC, 2010
- Association of Serum Digoxin Concentration and Outcomes in Patients With Heart FailureJAMA, 2003
- Female sex as an important determinant of lisinopril-induced coughThe Lancet, 1992